
|Articles|April 14, 2008
Bendamustine approved by FDA for chronic lymphocytic leukemia
Bendamustine has been approved by the FDA for the treatment of CLL
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
Vaccine Policy in Flux: Stories Pharmacists Need to Follow
3
Q&A: Pharmacists Help Patients Navigate Pneumococcal Vaccine Options
4
Pharmacists Are Essential Drivers of Opioid Stewardship Programs
5






























